Evidence map›Paper›PMID 19575148›Full record

ArticleJournal of neuro-oncology2010

[11C]-L-methionine positron emission tomography in the management of children and young adults with brain tumors.

Norbert Galldiks, Lutz W Kracht, Frank Berthold, Hrvoje Miletic, Johannes C Klein, Karl Herholz, Andreas H Jacobs, Wolf-Dieter Heiss

Open access · hybridAbstract read
In one paragraph

Article in Journal of neuro-oncology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 68 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Neuro-oncology practice · 2018
    Article
  8. Article
  9. Prognostic value of molecular and imaging biomarkers in patients with supratentorial glioma.European journal of nuclear medicine and molecular imaging · 2017
    Article
  10. Article
  11. Nuclear Medicine Imaging in Pediatric Neurology.Molecular imaging and radionuclide therapy · 2016
    Article
  12. Utility ofAmerican journal of nuclear medicine and molecular imaging · 2016
    Article
  13. Article
  14. Oligodendroglial component complicates the prediction of tumour grading with metabolic imaging.European journal of nuclear medicine and molecular imaging · 2015
    Article
  15. (18)F-FET-PET guided surgical biopsy and resection in children and adolescence with brain tumors.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2015
    Article
  16. Review
  17. Article
  18. Progress on the diagnosis and evaluation of brain tumors.Cancer imaging : the official publication of the International Cancer Imaging Society · 2013
    Review
  19. Value of 11C-methionine PET in imaging brain tumours and metastases.European journal of nuclear medicine and molecular imaging · 2013
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Norbert GalldiksDepartment of Neurology, University of Cologne, Kerpener Str. 62, 50924 Cologne, Germany. Norbert.Galldiks@uk-koeln.de
Lutz W Kracht
Frank Berthold
Hrvoje Miletic
Johannes C Klein
Karl Herholz
Andreas H Jacobs
Wolf-Dieter Heiss
Max Planck Institute for Metabolism Research · DEUniversity of Cologne · DEUniversity Hospital Cologne · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Only a few Methyl-[11C]-L-methionine (MET) positron emission tomography (PET) studies have focused on children and young adults with brain neoplasm. Due to radiation exposure, long scan acquisition time, and the need for sedation in young children MET-PET studies should be restricted to this group of patients when a decision for further therapy is not possible from routine diagnostic procedures alone, e.g., structural imaging. We investigated the diagnostic accuracy of MET-PET for the differentiation between tumorous and non-tumorous lesions in this group of patients. Forty eight MET-PET scans from 39 patients aged from 2 to 21 years (mean 15 +/- 5.0 years) were analyzed. The MET tumor-uptake relative to a corresponding control region was calculated. A receiver operating characteristic (ROC) was performed to determine the MET-uptake value that best distinguishes tumorous from non-tumorous brain lesions. A differentiation between tumorous (n = 39) and non-tumorous brain lesions (n = 9) was possible at a threshold of 1.48 of relative MET-uptake with a sensitivity of 83% and a specificity of 92%, respectively. A differentiation between high grade malignant lesions (mean MET-uptake = 2.00 +/- 0.46) and low grade tumors (mean MET-uptake = 1.84 +/- 0.31) was not possible. There was a significant difference in MET-uptake between the histologically homogeneous subgroups of astrocytoma WHO grade II and anaplastic astrocytoma WHO grade III (P = 0.02). MET-PET might be a useful tool to differentiate tumorous from non-tumorous lesions in children and young adults when a decision for further therapy is difficult or impossible from routine structural imaging procedures alone.

Indexed as

Carbon RadioisotopesAdolescentBrain NeoplasmsChildChild, PreschoolFemaleHumansMagnetic Resonance ImagingMaleMethioninePositron-Emission TomographyROC CurveYoung AdultCarbon RadioisotopesMethioninemethionine methyl ester

Identifiers

PMID19575148
PMCPMC2808525
OpenAlexW2168910075

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.